InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（19 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
19
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Klein Matthew B., Directeur et COO. Insider active across 2 companies, notably ClearPoint Neuro, Inc.. Aggregated, 34 filings have been published. Split: 0 buy · 19 sells. Total volume traded: €3.8m. History available since 25 June 2021. The latest transaction was disclosed on 4 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Klein Matthew B.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报34 总计
10,292 股@ US$68.570.012% mcap14.5% 占其流量Common StockSEC:0001808968-26-000017:0
16,000 股@ US$11.590.039% mcap100.0% 占其流量Common StockSEC:0001193125-26-239431:0
12,417 股Common StockSEC:0001193125-26-234577:0
12,500 股0Common StockSEC:0001808968-26-000015:0
2,850 股@ US$70.910.0027% mcap11.0% 占其流量Common StockSEC:0001808968-26-000013:0
12,500 股0Common StockSEC:0001808968-26-000011:0
7,371 股@ US$69.3614.4% 占其流量Common StockSEC:0001808968-26-000009:0
2,514 股@ US$76.455.5% 占其流量Common StockSEC:0001808968-26-000007:0
5,149 股@ US$76.9511.3% 占其流量Common StockSEC:0001808968-26-000005:0
63,000 股0Common StockSEC:0001808968-26-000003:0
8,089 股@ US$76.6417.6% 占其流量Common StockSEC:0001808968-26-000001:0
15,625 股0Common StockSEC:0001808968-25-000003:0
75,000 股0Common StockSEC:0001415889-25-021130:0
21,093 股Common StockSEC:0000950170-25-074448:0
2,804 股@ US$48.7368.7% 占其流量Common StockSEC:0001415889-25-011290:0
3,897 股@ US$50.09613.5% 占其流量Common StockSEC:0001415889-25-005136:0
2,142 股@ US$45.346.7% 占其流量Common StockSEC:0001415889-25-001293:0
70,000 股0Common StockSEC:0001415889-25-001015:0
8,279 股@ US$45.1625.9% 占其流量Common StockSEC:0001415889-25-000580:0
17,153 股Common StockSEC:0001285550-24-000056:0
3,361 股@ US$24.8945.7% 占其流量Common StockSEC:0001415889-24-011329:0
1,307 股@ US$25.1352.2% 占其流量Common StockSEC:0001415889-24-011247:0
70,000 股0Common StockSEC:0001415889-24-004106:0
2,237 股@ US$28.64034.2% 占其流量Common StockSEC:0001415889-24-000915:0
10,107 股@ US$27.148818.1% 占其流量Common StockSEC:0001415889-24-000854:0
34 条申报中的 25 条
About Klein Matthew B.
Klein Matthew B. is Director and COO. He has filed 33 filings in total, and in the recent filings observed between 2021-06-28 and 2026-05-26, all transactions are sales for a total of EUR 3,152,288, with notable sales in PTC Therapeutics, INC. and ClearPoint Neuro, Inc.
